Position in JNJ
as of Jun 30, 2026
· filed Jul 30, 2026
Position Value
$3,727,771
+$203,191 QoQ
Shares Held
14,678
+1.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.97%
of 13F equity value
Holder Rank
#1,833
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MV CAPITAL MANAGEMENT, INC. holds $82,370,025 across 15 Drug Manufacturers - General names. JNJ ranks #2 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
271,250 | $68,257,350 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
14,678 | $3,727,771 | |
| 3 | AMGN |
Amgen Inc
|
8,630 | $3,125,095 | |
| 4 | LLY |
ELI LILLY & Co
|
2,477 | $2,970,988 | |
| 5 | MRK |
Merck & Co., Inc.
|
22,792 | $2,928,772 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
7,582 | $957,909 | |
| 7 | PFE |
Pfizer Inc
|
10,065 | $242,365 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,153 | $66,435 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,727,771 | 14,678 | Shares | Sole | 2026-07-30 | |
| 2026-03-31 | $3,524,580 | 14,419 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,034,507 | 14,663 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $2,754,043 | 14,853 | Shares | Sole | 2026-02-23 | |
| 2025-06-30 | $2,815,640 | 18,433 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,184,625 | 19,203 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $2,906,428 | 20,097 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $3,279,932 | 20,239 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,758,623 | 18,874 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,996,434 | 18,942 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $2,820,536 | 17,995 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $2,774,219 | 17,812 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $2,894,448 | 17,487 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $2,596,560 | 16,752 | Shares | Sole | 2023-04-26 | |
| 2022-12-31 | $3,007,996 | 17,028 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,749,512 | 16,831 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $2,908,323 | 16,384 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $2,823,451 | 15,931 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $2,617,542 | 15,301 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $2,334,321 | 14,454 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $2,234,203 | 13,562 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $2,126,031 | 12,936 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $1,779,653 | 11,308 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,401,407 | 9,413 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $1,083,694 | 7,706 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $871,489 | 6,646 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||